Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 9801063, 11 pages
http://dx.doi.org/10.1155/2016/9801063
Review Article

Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis

1Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
3Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

Received 29 February 2016; Revised 13 June 2016; Accepted 5 July 2016

Academic Editor: Roberto César P. Lima-Júnior

Copyright © 2016 Jingwen Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Friedl and S. Alexander, “Cancer invasion and the microenvironment: plasticity and reciprocity,” Cell, vol. 147, no. 5, pp. 992–1009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. T. L. Whiteside, “The tumor microenvironment and its role in promoting tumor growth,” Oncogene, vol. 27, no. 45, pp. 5904–5912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. R. Langley and I. J. Fidler, “The seed and soil hypothesis revisited—the role of tumor-stroma interactions in metastasis to different organs,” International Journal of Cancer, vol. 128, no. 11, pp. 2527–2535, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. F. Leitch, M. Chakrabarti, J. E. M. Crozier et al., “Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer,” British Journal of Cancer, vol. 97, no. 9, pp. 1266–1270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Templeton, M. G. McNamara, B. Šeruga et al., “Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis,” Journal of the National Cancer Institute, vol. 106, no. 6, Article ID dju124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. T. F. Nishijima, H. B. Muss, S. S. Shachar, K. Tamura, and Y. Takamatsu, “Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis,” Cancer Treatment Reviews, vol. 41, no. 10, pp. 971–978, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-J. Teng, J. Zhang, T.-Y. Zhang, S. Zhang, and B.-S. Li, “Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis,” OncoTargets and Therapy, vol. 9, pp. 37–47, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and P. Group, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 7, Article ID e1000097, 2009. View at Publisher · View at Google Scholar
  11. W. C. W. Wong, C. S. K. Cheung, and G. J. Hart, “Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours,” Emerging Themes in Epidemiology, vol. 5, article 23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. K. B. Parmar, V. Torri, and L. Stewart, “Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints,” Statistics in Medicine, vol. 17, no. 24, pp. 2815–2834, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Google Scholar · View at Scopus
  14. J. P. T. Higgins and S. G. Thompson, “Controlling the risk of spurious findings from meta-regression,” Statistics in Medicine, vol. 23, no. 11, pp. 1663–1682, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Knapp and J. Hartung, “Improved tests for a random effects meta-regression with a single covariate,” Statistics in Medicine, vol. 22, no. 17, pp. 2693–2710, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Egger, G. Davey Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” The British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. J. P. T. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. Deng, B. He, X. Liu et al., “Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model,” Journal of Translational Medicine, vol. 13, no. 1, article 66, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. L.-H. Han, Y.-B. Jia, Q.-X. Song, J.-B. Wang, N.-N. Wang, and Y.-F. Cheng, “Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 6, pp. 2245–2250, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Huang and J.-F. Feng, “Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma,” OncoTargets and Therapy, vol. 8, pp. 137–145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. M. Kozak, R. von Eyben, J. S. Pai et al., “The prognostic significance of pretreatment hematologic parameters in patients undergoing resection for colorectal cancer,” American Journal of Clinical Oncology, In press.
  22. Z.-X. Lin, D.-Y. Ruan, Y. Li et al., “Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection,” World Journal of Gastroenterology, vol. 21, no. 38, pp. 10898–10906, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-S. Liu, Y. Huang, X. Yang, and J.-F. Feng, “A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma,” American Journal of Cancer Research, vol. 5, no. 7, pp. 2180–2189, 2015. View at Google Scholar
  24. C. P. Neal, V. Cairns, M. J. Jones et al., “Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases,” Medical Oncology, vol. 32, no. 5, p. 144, 2015. View at Publisher · View at Google Scholar
  25. K. Neofytou, E. C. Smyth, A. Giakoustidis et al., “The preoperative lymphocyte-to-monocyte ratio is prognostic of clinical outcomes for patients with liver-only colorectal metastases in the neoadjuvant setting,” Annals of Surgical Oncology, vol. 22, no. 13, pp. 4353–4362, 2015. View at Publisher · View at Google Scholar
  26. T. Ozawa, S. Ishihara, K. Kawai et al., “Impact of a lymphocyte to monocyte ratio in stage IV colorectal cancer,” The Journal of Surgical Research, vol. 199, no. 2, pp. 386–392, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Qi, Y. Geng, M. Sun, P. Wang, and Z. Chen, “Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer,” Pancreatology, vol. 15, no. 2, pp. 145–150, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Shibutani, K. Maeda, H. Nagahara et al., “Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer,” World Journal of Gastroenterology, vol. 21, no. 34, pp. 9966–9973, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Song, W. Eo, and S. Lee, “Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients,” World Journal of Gastroenterology, vol. 21, no. 43, pp. 12410–12420, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Stotz, M. Pichler, G. Absenger et al., “The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer,” British Journal of Cancer, vol. 110, no. 2, pp. 435–440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Stotz, J. Szkandera, T. Stojakovic et al., “The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer,” Clinical Chemistry and Laboratory Medicine, vol. 53, no. 3, pp. 499–506, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. W.-W. Xiao, L.-N. Zhang, K.-Y. You et al., “A low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in pathological T3N0 rectal cancer patients following total mesorectal excision,” Journal of Cancer, vol. 6, no. 7, pp. 616–622, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Zhou, Y. Du, J. Xu et al., “The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer,” Tumor Biology, vol. 35, no. 11, pp. 11659–11666, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. J. C. Chan, D. L. Chan, C. I. Diakos et al., “The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer,” Annals of Surgery, 2016. View at Publisher · View at Google Scholar
  35. A. Facciorusso, V. D. Prete, N. Crucinio, G. Serviddio, G. Vendemiale, and N. Muscatiello, “Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases,” World Journal of Gastroenterology, vol. 22, no. 16, pp. 4211–4218, 2016. View at Publisher · View at Google Scholar
  36. J. T. Hsu, C. C. Wang, P. H. Le et al., “Lymphocyte-to-monocyte ratios predict gastric cancer surgical outcomes,” The Journal of Surgical Research, vol. 202, no. 2, pp. 284–290, 2016. View at Publisher · View at Google Scholar
  37. G. J. Li, H. W. Xu, J. J. Ji, F. Yang, and B. Q. Gao, “Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma,” Journal of OncoTargets and Therapy, vol. 9, pp. 1085–1092, 2016. View at Publisher · View at Google Scholar
  38. Y. Li, H. Jia, W. Yu et al., “Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection,” International Journal of Cancer, vol. 139, no. 1, pp. 220–231, 2016. View at Publisher · View at Google Scholar
  39. S. J. Wu, Y. X. Lin, H. Ye, F. Y. Li, X. Z. Xiong, and N. S. Cheng, “Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy,” Journal of Surgical Oncology, vol. 114, no. 2, pp. 202–210, 2016. View at Publisher · View at Google Scholar
  40. K. Milne, C. Alexander, J. R. Webb et al., “Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes,” Journal of Translational Medicine, vol. 10, no. 1, article 33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Haruki, H. Shiba, Y. Fujiwara et al., “Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection,” Journal of Surgical Oncology, vol. 106, no. 1, pp. 31–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. S. A. Rosenberg, “Progress in human tumour immunology and immunotherapy,” Nature, vol. 411, no. 6835, pp. 380–384, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. G. P. Dunn, L. J. Old, and R. D. Schreiber, “The immunobiology of cancer immunosurveillance and immunoediting,” Immunity, vol. 21, no. 2, pp. 137–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Rabinowich, R. Cohen, I. Bruderman, Z. Steiner, and A. Klajman, “Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes,” Cancer Research, vol. 47, no. 1, pp. 173–177, 1987. View at Google Scholar · View at Scopus
  45. T. A. Zikos, A. D. Donnenberg, R. J. Landreneau, J. D. Luketich, and V. S. Donnenberg, “Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer,” Cancer Immunology, Immunotherapy, vol. 60, no. 6, pp. 819–827, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. I. J. Fidler and A. J. Schroit, “Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self,” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, vol. 948, no. 2, pp. 151–173, 1988. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Heuff, H. S. A. Oldenburg, H. Boutkan et al., “Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells,” Cancer Immunology Immunotherapy, vol. 37, no. 2, pp. 125–130, 1993. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Karnevi, R. Andersson, and A. H. Rosendahl, “Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion,” Immunology and Cell Biology, vol. 92, no. 6, pp. 543–552, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. J. W. Pollard, “Tumour-educated macrophages promote tumour progression and metastasis,” Nature Reviews Cancer, vol. 4, no. 1, pp. 71–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Mantovani, B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco, “The origin and function of tumor-associated macrophages,” Immunology Today, vol. 13, no. 7, pp. 265–270, 1992. View at Publisher · View at Google Scholar · View at Scopus
  51. J. W. Pollard, “Trophic macrophages in development and disease,” Nature Reviews Immunology, vol. 9, no. 4, pp. 259–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. L. M. Coussens, C. L. Tinkle, D. Hanahan, and Z. Werb, “MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis,” Cell, vol. 103, no. 3, pp. 481–490, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Sica, P. Allavena, and A. Mantovani, “Cancer related inflammation: the macrophage connection,” Cancer Letters, vol. 267, no. 2, pp. 204–215, 2008. View at Publisher · View at Google Scholar · View at Scopus